Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04814732
Title Expanded Access Program of Surufatinib
Recruitment No longer available
Gender both
Phase Expanded access
Variant Requirements No
Sponsors Hutchison Medipharma Limited
Indications

neuroendocrine tumor

Therapies

Surufatinib

Age Groups: adult | child | senior
Covered Countries USA

Facility Status City State Zip Country Details
Rocky Mountain Cancer Center Denver Colorado 80218 United States Details
Mercy Medical Center, Medical Oncology & Hematology Baltimore Maryland 21202 United States Details
Karmanos Cancer Center Detroit Michigan 48201 United States Details
MidAmerica Cancer Care Kansas City Missouri 64114 United States Details
Summit Medical Group Florham Park New Jersey 07932 United States Details
Roswell Park Cancer Institute Buffalo New York 14263 United States Details
Providence Cancer Institute Franz Clinic, Providence Health & Services Portland Oregon 97213 United States Details
Avera Cancer Institute Sioux Falls South Dakota 57105 United States Details
Texas Oncology - Baylor Charles A. Sammons Cancer Center Dallas Texas 75246 United States Details
Intermountain Healthcare Murray Utah 84107 United States Details
Intermountain Cancer Center Saint George Utah 84790 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field